BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 26689204)

  • 1. Intranasal Delivery of Exendin-4 Confers Neuroprotective Effect Against Cerebral Ischemia in Mice.
    Zhang H; Meng J; Zhou S; Liu Y; Qu D; Wang L; Li X; Wang N; Luo X; Ma X
    AAPS J; 2016 Mar; 18(2):385-94. PubMed ID: 26689204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pro-GLP-1, a Pro-drug of GLP-1, is neuroprotective in cerebral ischemia.
    Zhang H; Meng J; Li X; Zhou S; Qu D; Wang N; Jia M; Ma X; Luo X
    Eur J Pharm Sci; 2015 Apr; 70():82-91. PubMed ID: 25640912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Orally Active Allosteric GLP-1 Receptor Agonist Is Neuroprotective in Cellular and Rodent Models of Stroke.
    Zhang H; Liu Y; Guan S; Qu D; Wang L; Wang X; Li X; Zhou S; Zhou Y; Wang N; Meng J; Ma X
    PLoS One; 2016; 11(2):e0148827. PubMed ID: 26863436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated administration of exendin-4 reduces focal cerebral ischemia-induced infarction in rats.
    Briyal S; Gulati K; Gulati A
    Brain Res; 2012 Jan; 1427():23-34. PubMed ID: 22055454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The glucagon-like peptide-1 receptor agonist exendin-4 ameliorates warfarin-associated hemorrhagic transformation after cerebral ischemia.
    Chen F; Wang W; Ding H; Yang Q; Dong Q; Cui M
    J Neuroinflammation; 2016 Aug; 13(1):204. PubMed ID: 27566245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal delivery of progesterone after transient ischemic stroke decreases mortality and provides neuroprotection.
    Fréchou M; Zhang S; Liere P; Delespierre B; Soyed N; Pianos A; Schumacher M; Mattern C; Guennoun R
    Neuropharmacology; 2015 Oct; 97():394-403. PubMed ID: 26079443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent and long-term cerebroprotective effects of intranasal delivery of progesterone after ischemic stroke in male mice.
    Fréchou M; Zhu X; Liere P; Pianos A; Schumacher M; Mattern C; Guennoun R
    Neuropharmacology; 2020 Jun; 170():108038. PubMed ID: 32151648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal delivery of erythropoietin plus insulin-like growth factor-I for acute neuroprotection in stroke. Laboratory investigation.
    Fletcher L; Kohli S; Sprague SM; Scranton RA; Lipton SA; Parra A; Jimenez DF; Digicaylioglu M
    J Neurosurg; 2009 Jul; 111(1):164-70. PubMed ID: 19284235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exendin-4 reduces ischemic brain injury in normal and aged type 2 diabetic mice and promotes microglial M2 polarization.
    Darsalia V; Hua S; Larsson M; Mallard C; Nathanson D; Nyström T; Sjöholm Å; Johansson ME; Patrone C
    PLoS One; 2014; 9(8):e103114. PubMed ID: 25101679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gliptin-mediated neuroprotection against stroke requires chronic pretreatment and is independent of glucagon-like peptide-1 receptor.
    Darsalia V; Larsson M; Lietzau G; Nathanson D; Nyström T; Klein T; Patrone C
    Diabetes Obes Metab; 2016 May; 18(5):537-41. PubMed ID: 26847506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exendin-4-loaded PLGA microspheres relieve cerebral ischemia/reperfusion injury and neurologic deficits through long-lasting bioactivity-mediated phosphorylated Akt/eNOS signaling in rats.
    Chien CT; Jou MJ; Cheng TY; Yang CH; Yu TY; Li PC
    J Cereb Blood Flow Metab; 2015 Nov; 35(11):1790-803. PubMed ID: 26058696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal recombinant human erythropoietin protects rats against focal cerebral ischemia.
    Yu YP; Xu QQ; Zhang Q; Zhang WP; Zhang LH; Wei EQ
    Neurosci Lett; 2005 Oct; 387(1):5-10. PubMed ID: 16054296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal Delivery of Apelin-13 Is Neuroprotective and Promotes Angiogenesis After Ischemic Stroke in Mice.
    Chen D; Lee J; Gu X; Wei L; Yu SP
    ASN Neuro; 2015; 7(5):. PubMed ID: 26391329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exendin-4 induces a novel extended effect of ischemic tolerance via crosstalk with IGF-1R.
    Zhang H; Liu Y; Cheng L; Ma X; Luo X
    Brain Res Bull; 2021 Apr; 169():145-155. PubMed ID: 33197537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ischemia-induced changes in glucagon-like peptide-1 receptor and neuroprotective effect of its agonist, exendin-4, in experimental transient cerebral ischemia.
    Lee CH; Yan B; Yoo KY; Choi JH; Kwon SH; Her S; Sohn Y; Hwang IK; Cho JH; Kim YM; Won MH
    J Neurosci Res; 2011 Jul; 89(7):1103-13. PubMed ID: 21472764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apelin-36, a potent peptide, protects against ischemic brain injury by activating the PI3K/Akt pathway.
    Gu Q; Zhai L; Feng X; Chen J; Miao Z; Ren L; Qian X; Yu J; Li Y; Xu X; Liu CF
    Neurochem Int; 2013 Nov; 63(6):535-40. PubMed ID: 24083989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exendin-4 Inhibits Matrix Metalloproteinase-9 Activation and Reduces Infarct Growth After Focal Cerebral Ischemia in Hyperglycemic Mice.
    Kuroki T; Tanaka R; Shimada Y; Yamashiro K; Ueno Y; Shimura H; Urabe T; Hattori N
    Stroke; 2016 May; 47(5):1328-35. PubMed ID: 26979865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic treatment with a low dose of lithium protects the brain against ischemic injury by reducing apoptotic death.
    Xu J; Culman J; Blume A; Brecht S; Gohlke P
    Stroke; 2003 May; 34(5):1287-92. PubMed ID: 12677021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preconditioning with the traditional Chinese medicine Huang-Lian-Jie-Du-Tang initiates HIF-1α-dependent neuroprotection against cerebral ischemia in rats.
    Zhang Q; Bian H; Li Y; Guo L; Tang Y; Zhu H
    J Ethnopharmacol; 2014 Jun; 154(2):443-52. PubMed ID: 24751364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal administration of Exendin-4 antagonizes Aβ31-35-induced disruption of circadian rhythm and impairment of learning and memory.
    Wang X; Wang L; Xu Y; Yu Q; Li L; Guo Y
    Aging Clin Exp Res; 2016 Dec; 28(6):1259-1266. PubMed ID: 26920423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.